Toronto Dominion Bank’s Grace Therapeutics GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10
| Closed | – | – | 1745 |
|
|
2022
Q2 | $0 | Buy |
+10
| New | +$61 | ﹤0.01% | 1962 |
|
|
2022
Q1 | – | Sell |
-14
| Closed | – | – | 2071 |
|
|
2021
Q4 | $0 | Buy |
+14
| New | +$126 | ﹤0.01% | 2076 |
|
|
2021
Q3 | – | Sell |
-10
| Closed | – | – | 1499 |
|
|
2021
Q2 | $0 | Buy |
+10
| New | +$244 | ﹤0.01% | 1517 |
|
|
2021
Q1 | – | Sell |
-4
| Closed | – | – | 1597 |
|
|
2020
Q4 | $0 | Buy |
+4
| New | +$46 | ﹤0.01% | 1453 |
|
|
2019
Q4 | – | Sell |
-2
| Closed | – | – | 1579 |
|
|
2019
Q3 | $0 | Buy |
+2
| New | +$185 | ﹤0.01% | 1713 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | – | – | 1793 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1771 |
|
|
2018
Q4 | $0 | Buy |
+1
| New | +$44 | ﹤0.01% | 1690 |
|
|
2018
Q3 | – | Sell |
-2
| Closed | – | – | 1610 |
|
|
2018
Q2 | $0 | Buy |
2
+1
| +100% | +$38 | ﹤0.01% | 1584 |
|
|
2018
Q1 | $0 | Buy |
+1
| New | +$49 | ﹤0.01% | 1435 |
|
|
2017
Q4 | – | Sell |
-2
| Closed | -$134 | – | 1314 |
|
|
2017
Q3 | $0 | Sell |
2
-2
| -50% | -$126 | ﹤0.01% | 1254 |
|
|
2017
Q2 | $0 | Buy |
4
+3
| +300% | +$187 | ﹤0.01% | 1293 |
|
|
2017
Q1 | $0 | Sell |
1
-5
| -83% | -$307 | ﹤0.01% | 1293 |
|
|
2016
Q4 | $0 | Buy |
6
+5
| +500% | +$336 | ﹤0.01% | 1318 |
|
|
2016
Q3 | $0 | Sell |
1
-12
| -92% | -$888 | ﹤0.01% | 1268 |
|
|
2016
Q2 | $1K | Buy |
13
+9
| +225% | +$612 | ﹤0.01% | 1173 |
|
|
2016
Q1 | $0 | Buy |
+4
| New | +$313 | ﹤0.01% | 1300 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | – | – | 1119 |
|
|
2015
Q2 | $0 | Buy |
+1
| New | +$186 | ﹤0.01% | 1153 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | – | – | 1104 |
|
|
2014
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1076 |
|
|
2014
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1060 |
|
|
2014
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1095 |
|
|
2014
Q1 | $1K | Sell |
1
-1
| -50% | -$609 | ﹤0.01% | 1040 |
|
|
2013
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 1010 |
|
|
2013
Q3 | $2K | Hold |
2
| – | – | ﹤0.01% | 753 |
|
|
2013
Q2 | $2K | Buy |
+2
| New | +$2.41K | ﹤0.01% | 771 |
|
Other funds holding GRCE
TSS
FDCDDQ
TWC
Toronto Dominion Bank's GRCE Position: Q3 2022 in Review
Toronto Dominion Bank sold out of Grace Therapeutics (GRCE) in Q3 2022, closing a stake of 10 shares.
Toronto Dominion Bank first reported a position in GRCE in Q2 2013 and held it in 24 quarters. The position peaked at $2K in Q3 2013. 9 funds tracked by Wall St. Rank hold GRCE as of Q3 2022.
- Toronto Dominion Bank reported no remaining Grace Therapeutics position as of Q3 2022 after selling out during the quarter.
- Toronto Dominion Bank sold 10 Grace Therapeutics shares in Q3 2022.
- Toronto Dominion Bank first reported a position in Grace Therapeutics in Q2 2013 and held it in 24 quarters.
- Toronto Dominion Bank's Grace Therapeutics position peaked at $2K in Q3 2013.
- 9 funds tracked by Wall St. Rank held Grace Therapeutics as of Q3 2022.
Based on Toronto Dominion Bank's 13F filing for Q3 2022, filed 9 Nov 2022.